Indonesia’s Kimia Farma to start selling Covid-19 vaccines to public

JAKARTA, July 11 (Bloomberg): Indonesia’s state-owned pharmaceutical company PT Kimia Farma will start selling vaccines to the public on Monday as the country seeks to accelerate inoculations and achieve herd immunity by the end of the year.

The company will use doses by Sinopharm Group Co. that are currently available for private programs, said Bambang Heriyanto, a spokesman for PT Bio Farma, the parent company of Kimia Farma. Apart from business entities, private health facilities can now also offer shots for individuals using vaccines that are not used by the government program, he said at a press briefing on Sunday.